Rights and permissions
About this article
Cite this article
High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations. Nat Rev Clin Oncol 6, 3–4 (2009). https://doi.org/10.1038/ncponc1268
Issue Date:
DOI: https://doi.org/10.1038/ncponc1268
- Springer Nature Limited